Duopharma Biotech Bhd (XKLS:7148) Change In Payables And Accrued Expense : RM0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Change In Payables And Accrued Expense?

Duopharma Biotech Bhd's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was RM0.0 Mil. It means Duopharma Biotech Bhd's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Duopharma Biotech Bhd's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was RM0.0 Mil. It means Duopharma Biotech Bhd's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Duopharma Biotech Bhd Change In Payables And Accrued Expense Historical Data

The historical data trend for Duopharma Biotech Bhd's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Change In Payables And Accrued Expense Chart

Duopharma Biotech Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Duopharma Biotech Bhd Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Duopharma Biotech Bhd Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.0 Mil.

Duopharma Biotech Bhd Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd Headlines

No Headlines